Heribert Pittner

Title: Heribert Pittner: Innovator in Cardio-Selective Compounds

Introduction

Heribert Pittner is a notable inventor based in Gmund, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cardio-selective compounds. With a total of 2 patents to his name, Pittner's work has the potential to impact cardiovascular treatments.

Latest Patents

Pittner's latest patents include innovative compounds such as 4-Ureido-2-acyl phenoxypropanolamine and various phenoxypropylamine derivatives. These compounds are characterized by their cardio-selective β-blocking action, which can be crucial in managing heart conditions. The detailed chemical structures and formulations highlight the complexity and potential applications of his inventions.

Career Highlights

Heribert Pittner is associated with Chemie Linz Aktiengesellschaft, where he has been instrumental in advancing pharmaceutical research. His expertise in chemical compounds has led to the development of new therapeutic options for patients with cardiovascular issues. His contributions to the field are recognized among peers and industry professionals.

Collaborations

Pittner has collaborated with notable colleagues such as Gerhard Zolss and Heimo Stormann-Menninger-Lerchenthal. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical sector.

Conclusion

Heribert Pittner's work exemplifies the intersection of innovation and healthcare, particularly in the development of compounds that can improve cardiovascular health. His patents reflect a commitment to advancing medical science and improving patient outcomes.